Over 9,000 deaths due to respiratory diseases in Delhi

New Delhi:  The national capital recorded 9,211 deaths due to respiratory diseases in 2024, up from 8,801 in 2023, continuing an upward trend seen over the past few years, according to the latest official data released by the Delhi Government.

Common types of respiratory diseases include asthma, pneumonia, lung cancer and Tuberculosis, often causing breathing related issues.

Circulatory diseases were found to be the top most cause of death in 2024, followed by infectious and parasitic diseases. The overall death rate in the national capital also showed a rise.

The total number of deaths in Delhi rose to 1,39,480 in 2024, compared to 1,32,391 deaths recorded the previous year. Of these, 85,391 were males, 54,051 were females, and 38 were classified under other genders. Of these, 90,883 deaths were medically certified.

The national capital has slightly improved on Infant Mortality Rate (IMR), which was recorded at 22.4 per 1000 live births which was 23.61 in 2023. IMR is a measure of deaths of infants under one year old.

According to the latest data, 21,262 deaths were due to circulatory disease — common types include choked arteries, stroke and heart failure. In 2023, this number was 15,714.

The second most common cause of death in the national capital at 16,060 was infectious and parasitic disease, usually spreading due to bacteria, virus and fungi, often via contaminated food and water. Such deaths saw a drop from the previous year recorded at 20,781.

A total of 3,06,459 live births were recorded in the city in 2024, which was 8,628 less than the previous year, the documents added.

The birth rate in 2024 was recorded at 14, down from 14.66 in 2023, while the death rate has increased from 6.16 in 2023 to 6.37 in 2024, the data showed. Birth and death rates are counted per 1,000 persons of a given place.

Delhi’s population is projected to rise to 2.65 crore in the next 10 years by 2036. According to data, 99.1 per cent of people under five years of age have a birth certificate.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg